Cost-Benefit Implications in the Surveillance of Lynch Syndrome Subjects

Hereditary diseases, especially tumours of the gastrointestinal (Gl) tract, are gaining interest throughout the world [1,2]. They represent a unique model for the understanding of the aetiology of cancer and its biological behaviour, enabling us to introduce preventive strategies and possibly newer, more sophisticated therapies which are currently being searched for by molecular biologists [3].